Data / Form D filings / AEOLUS PHARMACEUTICALS, INC.
AEOLUS PHARMACEUTICALS, INC.: Form D filings
AEOLUS PHARMACEUTICALS, INC., a pharmaceuticals company in Mission Viejo, CA, filed 8 Form D notices with the SEC between 2009 and 2015. The latest, on December 18, 2015, reports $6.7 million sold of a $6.7 million offering to 43 investors.
Find out what AEOLUS PHARMACEUTICALS, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 26361 CROWN VALLEY PARKWAY, SUITE 150, Mission Viejo, CA, 92691
- Phone
- (949) 481-9825
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1261734
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 18, 2015 | New notice | $6,747,360 | $6,747,360 | $0 | 43 | Dec 10, 2015 | sec.gov |
| Mar 6, 2013 | New notice | $3,615,500 | $3,615,500 | $0 | 17 | Feb 22, 2013 | sec.gov |
| Apr 18, 2012 | New notice | $690,050 | $690,050 | $0 | 8 | Apr 4, 2012 | sec.gov |
| Aug 19, 2010 | New notice | $2,000,000 | $1,000,000 | $1,000,000 | 2 | Aug 11, 2010 | sec.gov |
| Aug 9, 2010 | Amendment | $3,300,000 | $3,300,000 | $0 | 3 | Oct 6, 2009 | sec.gov |
| Nov 23, 2009 | Amendment | $3,300,000 | $1,650,000 | $1,650,000 | 3 | Oct 6, 2009 | sec.gov |
| Oct 9, 2009 | New notice | $3,300,000 | $1,650,000 | $1,650,000 | 3 | Oct 6, 2009 | sec.gov |
| Apr 6, 2009 | New notice | $1,500,000 | $1,500,000 | $0 | 2 | Mar 30, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Brian Day | Executive Officer | |
| Jeffrey A. Scott | Director | |
| John M. Farah, Jr. | Director | |
| CHRIS A. RALLIS | Director | |
| John M. Clerici | Director | |
| JOHN McMANUS | Executive Officer | |
| Mitchell D. Kaye | Director | |
| DAVID C. CAVALIER | Executive Officer, Director | |
| Ken A. Bright | Executive Officer | |
| AMIT A. KUMAR | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Dec 14, 2015 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what AEOLUS PHARMACEUTICALS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.